Clinical Trial Update: Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether Exenatide LAR or Dulaglutide affect variability in 24-hour heart rate and blood pressure in adults with type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Exenatide-LAR (exenatide)

Snippet

Sponsor: University of Guadalajara | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN